Asker Healthcare Group, the pan-European medical products and solutions provider, has agreed to acquire 100% of the shares of German Healthcare and Medicalprodukte Vertrieb Flensburg (GHC/MPF), two interlinked medical supplies companies in Germany.
The UK Competition and Markets Authority (CMA) has launched an investigation into acquisitions by US healthcare REIT Welltower of care homes managed by for-profit UK care operators Barchester, HC-One, Aria Care, and Danforth Care.
SSP Health is one of only a handful of corporately-run primary care chains in the UK. It was founded in 2002 by two GP partners, Dr. Shikha Pitalia and Dr. Sanjay Pitalia, who are married. It has since grown to 45 practices, most of which are located in the North West of England.
Odontia, Norway’s third largest dental chain by number of clinics, is understood to be on the market, with both private equity and strategic buyers circling, HBI has learnt.
Praemia REIM, Europe’s largest healthcare real estate investor with almost €17 billion healthcare assets under management, has bought out 100% of the shares of the asset and property management division of CAREIT, a healthcare real estate development, investment and advisory firm.
UK-based medical technology company Smith+Nephew has agreed to acquire US sports medicine business Integrity Orthopaedics in a deal valued at up to $450 million. The transaction includes an upfront cash payment of $225 million, with an additional $225 million contingent on performance over the next five years.
Belgian healthcare software provider Corilus has acquired French outpatient software specialist Sofia Développement from European mid-market private equity firm IK Partners and other investors. The merger creates a combined platform serving over 70,000 healthcare professionals across Belgium and France, with plans to expand further across Europe.
EQT Life Sciences, the life sciences investment arm of Swedish private equity group EQT, has invested in Boston-based developer of respiratory drugs Kinaset Therapeutics as part of a $103 million Series B funding round. The funding will support the development of frevecitinib, a new inhaled treatment for asthma patients whose condition is not well controlled by existing therapies.
TopzorgGroep has become the largest chain of physiotherapy practices in the Netherlands after a series of acquisitions. It has just bought out one of its biggest competitors, FysioHolland, a chain of 100 physiotherapy clinics which had revenue of €22 million and EBITDA of €1.2 million in 2024. Capital A, TopzorgGroep private equity owner since 2019, is likely to be looking to sell the group soon.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.